Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Effects of low energy emission therapy in chronic psychophysiological insomnia.

Pasche B, Erman M, Hayduk R, Mitler MM, Reite M, Higgs L, Kuster N, Rossel C, Dafni U, Amato D, Barbault A, Lebet JP.

Sleep. 1996 May;19(4):327-36.

PMID:
8776791
2.

Sleep inducing effect of low energy emission therapy.

Reite M, Higgs L, Lebet JP, Barbault A, Rossel C, Kuster N, Dafni U, Amato D, Pasche B.

Bioelectromagnetics. 1994;15(1):67-75.

PMID:
8155071
3.

Electroencephalographic changes following low energy emission therapy.

Lebet JP, Barbault A, Rossel C, Tomic Z, Reite M, Higgs L, Dafni U, Amato D, Pasche B.

Ann Biomed Eng. 1996 May-Jun;24(3):424-9.

PMID:
8734063
4.

Ramelteon for the treatment of insomnia.

Borja NL, Daniel KL.

Clin Ther. 2006 Oct;28(10):1540-55. Review.

PMID:
17157111
5.
6.

The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.

Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.

Sleep Med. 2009 Sep;10(8):859-64. doi: 10.1016/j.sleep.2008.10.005. Epub 2009 Mar 31.

PMID:
19345644
7.

Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.

Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E.

J Clin Psychiatry. 2001 Jun;62(6):453-63.

PMID:
11465523
8.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

9.

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.

Scharf M, Rogowski R, Hull S, Cohn M, Mayleben D, Feldman N, Ereshefsky L, Lankford A, Roth T.

J Clin Psychiatry. 2008 Oct;69(10):1557-64. Epub 2008 Oct 7.

PMID:
19192438
10.

Role of lormetazepam in the treatment of insomnia in the elderly.

De Vanna M, Rubiera M, Onor ML, Aguglia E.

Clin Drug Investig. 2007;27(5):325-32.

PMID:
17451280
11.

Serial partial sleep deprivation as adjuvant treatment of depressive insomnia.

Hemmeter U, Seifritz E, Hatzinger M, Müller MJ, Holsboer-Trachsler E.

Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jul;19(4):593-602.

PMID:
8588058
12.

[Effect of modified xiaoyao powder for improving sleep in patients with psychological stress insomnia].

Li Y, Xu BY, Xiao F.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Mar;29(3):208-11. Chinese.

PMID:
19548434
13.

Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia.

Cervena K, Dauvilliers Y, Espa F, Touchon J, Matousek M, Billiard M, Besset A.

J Sleep Res. 2004 Dec;13(4):385-93.

14.

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

Elie R, Rüther E, Farr I, Emilien G, Salinas E.

J Clin Psychiatry. 1999 Aug;60(8):536-44.

PMID:
10485636
15.

Situational insomnia: consistency, predictors, and outcomes.

Bonnet MH, Arand DL.

Sleep. 2003 Dec 15;26(8):1029-36.

PMID:
14746386
16.

Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.

Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M.

Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68. Review.

17.

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.

Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW.

Arch Intern Med. 2004 Sep 27;164(17):1888-96.

PMID:
15451764
18.

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.

Sleep Med. 2006 Jun;7(4):312-8. Epub 2006 May 18.

PMID:
16709464
19.

CAP variables and arousals as sleep electroencephalogram markers for primary insomnia.

Terzano MG, Parrino L, Spaggiari MC, Palomba V, Rossi M, Smerieri A.

Clin Neurophysiol. 2003 Sep;114(9):1715-23.

PMID:
12948801
Items per page

Supplemental Content

Write to the Help Desk